STOCKHOLDERS' EQUITY - Common Stock (Details) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| STOCKHOLDERS' EQUITY | |||
| Common stock, shares authorized | 1,580,000,000 | 1,580,000,000 | |
| Common stock, par value (in dollars per share) | $ 0.00001 | $ 0.00001 | |
| Sale of Common Stock (in shares) | 3,653,075 | 1,922,194 | |
| Proceeds from sale of common stock | $ 5,117,829 | $ 2,125,026 | |
| Incurred offering costs | $ 4,101,971 | $ 1,444,755 | |
| X | ||||||||||
- Definition Amount of incurred offering costs. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|